Serum levels of IL-8, IFNγ, IL-10, and TGF β and their gene expression levels in severe and non-severe cases of dengue virus infection

Archives of Virology

Volumn 160, Issue 6, 2015, Pages 1463-1475

  Pandey, Nidhi ^a   Jain, Amita ^a   Garg, R K ^a   Kumar, Rashmi ^a   Agrawal, O P ^b   Lakshmana Rao, P V ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b JIWAJI UNIVERSITY   (India)

^c BHARATHIAR UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VIRUS;

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA;

ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CHILD; DENGUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMAN; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENGUE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; HUMANS; INFANT; INFANT, NEWBORN; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-8; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 84929120465     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-015-2410-6     Document Type: Article

References (43)

1. Gubler DJ (2002) Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21th century. Trends Microbiol 10:100–103
2. Fink J, Gu F, Vasudevan SG (2006) Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev Med Virol 16(4):263–275
3. Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de Oliveira-Pinto LM (2006) Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz 101(4):437–449
4. Bethell DB, Flobbe K, Cao XT, Day NP, Pham TP, Buurman WA et al (1998) Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever. J Infect Dis 177(3):778–782
5. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak A et al (1999) Early immune activation in acute dengue illness is related to development of plasma leakage and disease severity. J Infect Dis 179(4):755–762
6. Braga EL, Moura P, Pinto LM, Ignacio SR, Oliveira MJ, Cordeiro MT et al (2001) Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever. Mem Inst Oswaldo Cruz 96(2):229–232
7. Marty AM, Jahrling PB, Geisbert TW (2006) Viral hemorrhagic fevers. Clin Lab Med 26(2):345–386
8. Kurane I, Ennis FA (1997) Immunopathogenesis of dengue virus infections. In: Gubler DJ, Kuno G (eds) Dengue and dengue haemorrhagic fever. CAB International, Oxford, pp 273–290
9. World Health Organization (2009) Dengue and dengue hemorrhagic fever. World Health Organization, Switzerland
10. Lanciotti RS, Calisher C, Gubler DJ, Chang G, Vorndam V (1992) Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase polymerase chain reaction. J Clin Virol 30:545–555
11. Green S, Vaughn DW, Kalayanarooj S, Nimmannitya S, Suntayakorn S, Nisalak Rothman AL et al (1999) Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J Med Virol 59:329–334
12. Chakravarti A, Kumaria R (2006) Circulating levels of tumor necrosis factor-alpha & interferon-gamma in patients with dengue & dengue haemorrhagic fever during an outbreak. Indian J Med Res 123(1):11–14
13. Bozza FA, Cruz OG, Zagne SM, Azeredo EL, Nogueira RM, Assis EF et al (2008) Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 8:86
14. Gavard J, Hou X, Qu Y, Masedunskas A, Martin D, Weigert R et al (2009) A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. Mol Cell Biol 29:2469–2480
15. Srikiatkhachorn A, Green S (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338:67–82
16. Raghupathy R, Chaturvedi UC, Al-Sayer H, Elbishbishi EA, Agarwal R, Nagar R et al (1998) Elevated levels of IL-8 in dengue hemorrhagic fever. J Med Virol 56(3):280–285
17. Priyadarshini D, Gadia RR, Tripathy A, Gurukumar KR, Bhagat A, Patwardhan S et al (2010) Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. PLoS One 5:e8709
18. Avirutnan P, Malasit P, Seliger B, Bhakdi S, Husmann M (1998) Dengue virus infection of human endothelial cells leads to chemokine production, complement activation, and apoptosis. J Immunol 161:6338–6346
19. Juffrie M, Van Der Meer GM, Hack CE, Haasnoot K, Sutaryo Veerman AJ et al (2000) Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation. Infect Immun 68:702–707
20. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M (2002) Multiple control of interleukin-8 gene expression. J Leukoc Biol 72:847–855
21. Chaturvedi UC, Elbishbishi EA, Agarwal R, Raghupathy R, Nagar R, Tandon R et al (1999) Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures. J Med Virol 59:335–340
22. Hober D, Poli L, Roblin B, Gestas P, Chungue E, Granic G et al (1993) Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), and interleukin-1 beta (IL-1 beta) in dengue-infected patients. Am J Trop Med Hyg 48:324–331
23. Baggiolini M, Loetscher P, Moser B (1995) Interleukin-8 and the chemokine family. Int J Immunopharmacol 17:103–108
24. Pace E, Gjomarkaj M, Melis M, Profita M, Spatafora M, Vignola AM et al (1999) Interleukin-8 induces lymphocyte chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit Care Med 159:1592–1599
25. Talavera D, Castillo AM, Dominguez MC, Gutierrez AE, Meza I (2004) IL-8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers. J Gen Virol 85:1801–1813
26. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, Le BL et al (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189(2):221–232
27. Libraty DH, Endy TP, Houng HS, Green S, Kalayanarooj S, Suntayakorn S, Chansiriwongs W et al (2002) Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infection. J Infect Dis 185(9):1213–1221
28. Malavige GN, Huang LC, Salimi M, Gomes L, Jayaratne SD, Ogg GS (2012) Cellular and cytokine correlates of severe dengue infection. PLoS One 7(11):e50387
29. Li MO, Flavell RA (2008) Contextual regulation of inflammation: a duet by transforming growth factor-β and interleukin-10. Immunity 28(4):468–476
30. Perez AB, Garcia G, Sierra B, Alvarez M, Vazquez S, Cabrera MV et al (2004) IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J Med Virol 73(3):230–234
31. Agarwal R, Elbishbishi EA, Chaturvedi UC, Nagar R, Mustafa AS (1999) Profile of transforming growth factor-beta 1 in patients with dengue haemorrhagic fever. Int J Exp Pathol 80:143–149
32. Rico-Hesse R, Harrison LM, Salas RA, Tovar D, Nisalak A, Ramos C et al (1997) Origins of dengue type 2 viruses associated with increased pathogenicity in the Americas. Virology 230:244–251
33. Mangada MM, Rothman AL (2005) Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J Immunol 175(4):2676–2683
34. Fried JR, Gibbons RV, Kalayanarooj S, Thomas SJ, Srikiatkhachorn A, Yoon I-K, Jarman RG, Green S, Rothman AL, Cummings DAT (2010) Serotype-specific differences in the risk of dengue hemorrhagic fever: an analysis of data collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl Trop Dis 4:e617
35. Dash PK, Parida MM, Saxena P, Kumar M, Rai A, Pasha ST et al (2004) Emergence and continued circulation of dengue-2 (genotype IV) virus strains in northern India. J Med Virol 74:314–322
36. Faria NR, Nogueira RM, de Filippis AM, Simoes JB, Nogueira Fde B, da Rocha Queiroz Lima M et al (2013) Twenty years of DENV-2 activity in Brazil: molecular characterization and phylogeny of strains isolated from 1990 to 2010. PLoS Negl Trop Dis 7(3):e2095
37. Macedo GA, de Araujo JM, Schatzmayr HG, Costa FA, de Filippis AM, Santos FB et al (2013) Virological surveillance for early warning of dengue epidemics in the State of Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 107:141–146
38. Pandey N, Nagar R, Gupta S, Omprakash Khan D, Singh DD et al (2012) Trend of dengue virus infection at Lucknow, north India (2008–2010): a hospital based study. Indian J Med Res 136:862–867
39. WHO (2002) Dengue and dengue haemorrhagic fever. Fact Sheet No. 117. WHO, Geneva
40. Rodriguez-Barraquer I, Cordeiro MT, Braga C, De Souza WV, Marques ET et al (2011) From re-emergence to hyper endemicity: the natural history of the dengue epidemic in Brazil. PLoS Negl Trop Dis 5:e935
41. Gamble J, Bethell D, Day NP, Loc PP, Phu NH, Gartside IB et al (2000) Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Colch) 98:211–216
42. Clamp M, Fry B, Kamal M, Xie X, Cuff J, Lin MF et al (2007) Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci USA 104(49):19428–19433
43. Shebl FM, Pinto LA, Garcia-Pineres A, Lempicki R, Williams M, Harro C et al (2010) Comparison of mRNA and protein measures of cytokines following vaccination with human papillomavirus-16 L1 virus-like particles. Cancer Epidemiol Biomark Prev 19(4):978–981